The CTS newsletters are available in PDF and HTML formats. For optimal graphics performance use PDF if your browser supports it (using the Adobe Acrobat Plug-in). You can also use the freely available Adobe Acrobat Reader to view PDF documents.
| Year
| Issue
| Topics
| Format
|
| 2008 |
1 |
Time of rejection and long-term graft survival |
PDF | HTML |
| |
2 |
Acute rejection and graft outcome in heart, lung, liver, pancreas transplantation |
PDF | HTML |
| 2007 |
1 |
Completeness of follow up; HLA matching and short ischemia |
PDF | HTML |
| |
2 |
Crossmatch Analysis |
PDF | HTML |
| |
3 |
Non-Heartbeating Donors, Hypertensive Donors, Other Marginal Donors |
PDF | HTML |
| |
4 |
Blood transfusions and antibodies against HLA and MICA |
PDF | HTML |
| 2006 |
1 |
Influence of center size and early success rate on long-term outcome of kidney, heart and liver transplants |
PDF | HTML |
| |
2 |
Antibody induction and incidence of non-Hodgkin lymphoma |
PDF | HTML |
| |
3 |
Lymphoma and antibody induction non-renal transplants. Overall CTS statistics. |
PDF | HTML |
| |
4 |
ACEI/ARB treatment and long-term kidney graft survival. |
PDF | HTML |
| 2005 |
1 |
Donor Age Effect, Steroid Withdrawal Study |
PDF | HTML |
| |
2 |
ABO incompatible kidney transplants |
PDF | HTML |
| |
3 |
Preoperative cyclosporine |
PDF | HTML |
| |
4 |
Successful control of posttransplant hypertension and kidney graft survival |
PDF | HTML |
| 2004 |
1 |
Quality of HLA typing, HLA matching in kidney transplantation |
PDF | HTML |
| |
2 |
Unrelated living donors, short ischemia, HLA matching |
PDF | HTML |
| |
3 |
Hypertension and ACE inhibitors |
PDF | HTML |
| |
4 |
Related donor and split liver transplants |
PDF | HTML |
| 2003 |
1 |
TaXi expansion, incidence of rectal cancer |
PDF | HTML |
| |
2 |
Influence of serum cholesterol in kidney and heart transplantation |
PDF | HTML |
| |
3 |
Pretransplant sCD30 and HLA matching |
PDF | HTML |
| |
4 |
Posttransplant Cancer |
PDF | HTML |
| 2002 |
1 |
Ischemic preservation time, anti-HLA antibodies |
PDF | HTML |
| |
2 |
Analysis of sCD30 in kidney transplantation. Announcement of prospective sCD30 and anti-HLA antibody study |
PDF | HTML |
| |
3 |
Combined kidney+liver and kidney+heart transplants |
PDF | HTML |
| 2001 |
1 |
Software Development / Generic Cyclosporine |
PDF | HTML |
| |
2 |
Cause of donor death |
PDF | HTML |
|
3 |
New database TaXi / HLA matching and modern immunosuppression |
PDF | HTML |
| |
4 |
Anti-HLA class I and class II antibodies |
PDF | HTML |
| 2000 |
1 |
DNA Typing Project / Pretransplant Risk Categories (continued) |
PDF | HTML |
| |
2 |
Improved Transplant Survival |
PDF | HTML |
| |
3 |
Center-specific Analysis |
PDF | HTML |
| |
4 |
Update Steroid Withdrawal Study, 4-Year Results |
PDF | HTML |
| 1999 |
1 |
Prospective Steroid Withdrawal Study |
PDF | HTML |
| |
2 |
Sibling Haplotype Project. Steroid Withdrawal Project |
PDF | HTML |
| |
3 |
Role of IgA-anti-Fab Antibodies |
PDF | HTML |
| |
4 |
CTS Website Update. Pretransplant Risk Assessment (Graft and Patient Survival) |
PDF | HTML |
| 1998 |
1 |
Blood Pressure and Graft Survival |
PDF | HTML |
| |
2 |
DNA Typing Project (A+B locus). Blood Pressure and Heart Transplants |
PDF | HTML |
| |
3 |
CYA Dosage and Graft Outcome. Steroid-free Maintenance |
PDF | HTML |
| |
4 |
Pretransplant CMV Status. CMV Prophylaxis |
PDF | HTML
|
| 1997 |
1 |
Posttransplant Malignancies |
PDF | HTML |
| |
2 |
HLA-DR+DP Broad/Split Specificity Matches. Importance of DNA Typing |
PDF | HTML |
| |
3 |
Randomized Transfusion Study |
PDF | HTML |
| |
4 |
HIT Project |
PDF | HTML |
| 1996 |
1 |
HLA Matching in non-renal Transplantation |
HTML |
| |
2 |
HLA matching in Heart Transplantation. Repeat Heart Transplants |
HTML |
| |
3 |
Molecular Typing for HLA-DRB. Recipient Age in Renal Transplantation |
PDF | HTML |
| |
4 |
Cold Ischemic Preservation Times. HLA Matching and Graft Survival with Short Cold Ischemia |
PDF | HTML |
| |
5 |
Early Immunological Rejection and Chronic Graft Loss Taboo Mismatches |
PDF | HTML |
| 1995 |
1 |
"Permissible" HLA mismatches |
HTML |
| |
2 |
HIT Trial for highly immunized patients |
HTML |
| |
3 |
"Graft Adaption" |
HTML |
| |
4 |
Induction Treatment with OKT3 |
HTML |
| 1994 |
1 |
Patient Survival after Diagnosis of Posttransplant Lymphomas |
HTML |
| |
2 |
HLA Matching in Heart Transplantation. Influence of Donor Age |
HTML |
| |
3 |
Maintenance Immunosuppression in Renal Transplant Recipients |
HTML |
| |
4 |
Steroid Withdrawal Project |
HTML |
| 1993 |
1 |
HLA Compatibility in Liver Transplantation |
HTML |
| |
2 |
Kidney Preservation Methods |
HTML |
| |
3 |
Impact of AB0 Compatibility / Incompatibility on Graft Survival |
HTML |
| |
4 |
XCOMB Allocation Method |
HTML |
| |
5 |
Posttransplant non-Hodgkin's Lymphomas |
HTML |
| 1992 |
1 |
Donor Age in Liver and Pancreas Transplantation. Relevance of HLA-A and -B Antigen Splits |
HTML |
| |
2 |
10th CTS Anniversary Symposium |
HTML |
| |
3 |
Discrepancies between Serological and DNA Typing |
HTML |
| |
4 |
Graft and Patient Survival for "Good", "Mediocre" or "Poor" Risk Patients |
HTML |
| 1991 |
1 |
Kidney Transplants from Live Unrelated Donors |
HTML |
| |
2 |
Analysis of Pancreas Transplants |
HTML |
| |
3 |
CMV Status of Transplant Recipients and Donors |
HTML |
| |
4 |
DNA-RFLP Project |
HTML |
| |
5 |
Donor Age in Kidney and Heart Transplantation |
HTML |
| 1990 |
1 |
Evolution of Kidney and Heart Transplant Studies |
HTML |
| |
2 |
Transplant Results for Different Diseases |
HTML |
| |
3 |
Sequential Immunosuppression for Kidney and Heart Transplantation |
HTML |
| |
4 |
Sequential Immunosuppression with OKT3 rather than ATG/ALG Induction |
HTML |
| |
5 |
Yearly Success Rates for Kidney, Heart, Liver and Pancreas Transplants |
HTML |
| |
6 |
Estimation of Long-Term Kidney Graft Survival Rates |
HTML |
| 1989 |
1 |
HLA Matching in Second Transplants |
HTML |
| |
2 |
Sequential Immunosuppression |
HTML |
| |
3 |
Role of Remote Positive Crossmatch |
HTML |
| |
4 |
Survival of Father to Child as compared to Mother to Child Transplants |
HTML |
| |
5 |
Heart and Kidney Transplants and the Alleged Nephrotoxic Effect of Cyclosporine |
HTML |
| |
6 |
Pancreas Transplants |
HTML |
| |
7 |
Matching for HLA Split Antigens |
HTML |
| 1988 |
1 |
Influence of Recipient/Donor Age |
HTML |
| |
2 |
59 verified AB0 Incompatible Cadaver Transplants |
HTML |
| |
3 |
Pretransplant Transfusions |
HTML |
| |
4 |
Importance of HLA Antigen "Splits" |
HTML |
| |
5 |
Preliminary Analysis of Immunosuppression Questionnaires |
HTML |
| |
6 |
Influence of HLA Matching with or without Cyclosporine |
HTML |
| 1987 |
1 |
HLA-B+DR Mismatches in First Cadaver Transplants |
HTML |
| |
2 |
Influence of Recipient Age |
HTML |
| |
3 |
Age and Patient Survival in different Disease Categories |
HTML |
| |
4 |
Explanation of Clinical Grades |
HTML |
| |
5 |
Type and Time of Dialysis |
HTML |
| |
6 |
Type and Time of Dialysis. Influence of HLA-B+DR Mismatches |
HTML |
| |
7 |
First and Second Transplants with Cyclosporine. Importance of Good Quality HLA Typing |
HTML |
| 1986 |
1 |
Comparison Cadaver Transplants with or without Cyclosporine |
HTML |
| |
2 |
Recipient / Donor Age, with or without Cyclosporine |
HTML |
| |
3 |
Preformed Lymphocytotoxic Antibodies |
HTML |
| |
4 |
High Level Antibodies and HLA Matching |
HTML |
| |
5 |
Retransplants |
HTML |
| |
6 |
Pretransplant Transfusions |
HTML |
| |
7 |
Influence of HLA-B+DR Matching on Cyclosporine-treated Transplants |
HTML |
| |
8 |
Patient and Graft Survival: Cyclosporine, Original Disease, Risk Factors |
HTML |
| 1985 |
1 |
Effect of HLA-A,-B and -DR Mismatches on Graft Survival |
HTML |
| |
2 |
Effect of Cyclosporine on Graft Survival |
HTML |
| |
3 |
Effect of Cyclosporine and HLA-B,-DR Mismatches on Graft Survival |
HTML |
| |
4 |
Survival Rates for "good", "moderate" or "poor" Risk Patients in Europe, North America and other Continents |
HTML |
| |
5 |
Comparison of Cyclosporine versus Conventional Immunosuppression in Children |
HTML |
| |
6 |
Introduction of CTS Sera Sets / Results of Crossmatch Analysis |
HTML |
| 1984 |
1 |
Cross Match Analysis Correlation of HLA Matching with Graft Outcome |
HTML |
| |
2 |
Analysis of Extended Red Cell Antigen Data, the Complement of Bf Markers and whether or not Donor was Transfused |
HTML |
| |
3 |
Survival in Patients with or without CyA |
HTML |
| |
4 |
Influence of Ischemia Times on Graft Survival |
HTML |
| |
5 |
Differential Effect of HLA Matching with Ischemia Times |
HTML |
| 1983 |
1 |
Transplant Results in Relation to Preformed Lymphocytotoxic Antibodies |
HTML |
| |
2 |
Analysis of Different Immunosuppressive Protocols. DR6 Effect on Graft Survival |
HTML |
| |
3 |
Combined Analysis of HLA-B plus HLA-DR on Graft Survival |
HTML |
| |
4 |
Matching for HLA-A,-B and -DR |
HTML |